Turn Therapeutics TTRX
NASDAQ TTRX
$10.58 +0.11 (+1.05%)
As of: Oct 21, 2026 · 2:06 PM EDT

Turn Therapeutics (TTRX) Non-Current Debt (2026)

Updated

Turn Therapeutics' Non-Current Debt came in at $6.06 million for Q2 2026, up 2.1% from the prior quarter.

Analysis

Turn Therapeutics (TTRX) Non-Current Debt (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,133.19 Bn 1,101.77 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 616.03 Bn 534.56 Bn 17.26 Bn 37.34 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn 62.48 Bn
4 Merck 366.82 Bn 321.20 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.82 Bn 261.81 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn 23.68 Bn
7 Amgen 235.89 Bn 191.29 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 190.64 Bn 164.84 Bn 6.22 Bn 23.83 Bn
9 Pfizer 169.32 Bn 115.96 Bn 10.94 Bn 60.50 Bn
10 Turn Therapeutics 315.16 Mn 288.27 Mn - 6.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.06 Mn
Mar 31, 2026 5.94 Mn
API Access

Turn Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=TTRX&period=max&api_key=YOUR_API_KEY